Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
IMPA1 encodes an enyzme that dephosphorylates myo-inositol monophosphate to generate free myo-inositol, a precursor of phosphatidylinositol, and is therefore an important modulator of intracellular signal transduction via the production of the second . De plus, nous expédions Inositol(myo)-1(or 4)-Monophosphatase 1 Protéines (18) et Inositol(myo)-1(or 4)-Monophosphatase 1 Kits (8) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 34 products:
Human Polyclonal IMPA1 Primary Antibody pour ELISA, WB - ABIN561484
Andreassi, Zimmermann, Mitter, Fusco, De Vita, Devita, Saiardi, Riccio: An NGF-responsive element targets myo-inositol monophosphatase-1 mRNA to sympathetic neuron axons. dans Nature neuroscience 2010
Show all 2 Pubmed References
IMPase has a role in intracellular myo (Montrer SYNPO2 Anticorps)-inositol synthesis in craniofacial development and the maintenance of proper brain function
local synthesis of IMPA1 is required for neurotrophin (Montrer BDNF Anticorps)-dependent axon growth; selective regulation of IMPA1 levels in axons may provide a target for the development of new therapeutic strategies for specific neurological and psychiatric diseases
IMPA1 was expressed in round spermatids
Results suggest that calbindin D28k (Montrer CALB1 Anticorps) acts as an activity-dependent sensor that targets membrane/cytoskeleton-bound myo (Montrer SYNPO2 Anticorps)-inositol monophosphatase in central neurons.
IMPA2 (Montrer IMPA2 Anticorps) has a separate function in vivo from that of IMPA1
IMPA1-/- mouse represents a novel model to study inositol homeostasis, and indicates that genetic inactivation of IMPA1 can mimic some actions of lithium
The identification of a novel homozygous duplication of 5 bp in IMPA1, in a large consanguineous family with nine individuals with severe intellectual disability and disruptive behavior.
The current study did not support a substantial role of the upregulation of IMPase in bipolar disorder, although the lithium-insensitivity trait seen in IMPA2 (Montrer IMPA2 Anticorps) transgenic mice might represent some aspect relevant to the inositol depletion hypothesis.
This gene encodes an enyzme that dephosphorylates myo-inositol monophosphate to generate free myo-inositol, a precursor of phosphatidylinositol, and is therefore an important modulator of intracellular signal transduction via the production of the second messengers myoinositol 1,4,5-trisphosphate and diacylglycerol. This enzyme can also use myo-inositol-1,3-diphosphate, myo-inositol-1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. This enzyme shows magnesium-dependent phosphatase activity and is inhibited by therapeutic concentrations of lithium. Inhibition of inositol monophosphate hydroylosis and subsequent depletion of inositol for phosphatidylinositol synthesis may explain the anti-manic and anti-depressive effects of lithium administered to treat bipolar disorder. Alternative splicing results in multiple transcript variants encoding distinct isoforms. A pseudogene of this gene is also present on chromosome 8q21.13.
inositol monophosphatase 1
, Inositol monophosphatase
, IMP 1
, IMPase 1
, inositol-1(or 4)-monophosphatase 1
, lithium-sensitive myo-inositol monophosphatase A1
, myo-inositol monophosphatase